The Kinsey Institute 

Nancy Ostrowski

Nancy L. Ostrowski, Ph.D.

Associate director

As associate director, Dr. Nancy Ostrowski is involved in all aspects of the Kinsey Institute’s research, collections, outreach, education, and funding programs.

Prior to joining the Kinsey Institute, Ostrowski held leadership and research roles at the National Institutes of Health—in academia, and in industry. Her research spans humans and animals, and she has made major contributions to understanding the effects of hormones, including testosterone, oxytocin, estrogen, and selective estrogen receptor modulators (SERMS).

Ostrowski has also described the role of hormones in modulating and integrating behavior and motivation and published on the following subjects:

  • Sex differences in brain and behavior
  • Expression of oxytocin and vasopressin receptor mRNAs and their modulation by hormones
  • Physiological and behavioral effects of opioids and opiate antagonists
  • Effects of sexual behavior on immune function

 nanostro@indiana.edu
 (812) 855-7686

Morrison Hall
Indiana University
Bloomington, IN 47405

Education

  • Ph.D., Psychobiology, University of Pittsburgh
  • M.S., Physiological Psychology, Rensselaer Polytechnic Institute
  • B.A., Psychology, Edinboro State University

Past experience

  • Academic research
  • Business
  • Government
  • Pharmaceuticals
  • Product development

Selected publications

Journal articles

  • Li, H., Swain, J., Benoit, K., Ostrowski, N., & Motsko, S. (2013, October). Baseline Characteristics and Comorbidities among United Kingdom Males Prior to Testosterone Treatment Compared to Non-Users Stratified by Body Mass Index (BMI). In Pharmacoepidemiology and Drug Safety (Vol. 22, pp. 58-58). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL.
  • Long, K. A., Goldish, M., Lown, E. A., Ostrowski, N. L., Alderfer, M. A., Marsland, A. L., & Ewing, L. J. (2015). Major lessons learned from a nationally-based community–academic partnership: Addressing sibling adjustment to childhood cancer. Families, Systems, & Health, 33(1), 61.
  • Li, H., Ostrowski, N. L., Benoit, K., Wang, W., & Motsko, S. P. (2015). Assessment of the Association Between the Use of Testosterone Replacement Therapy (TRT) and the Risk of Venous Thrombotic Events Among TRT-Treated and Untreated Hypogonadal Men. In Testosterone Replacement Therapy: Risks and Benefits (pp. OR34-2). Endocrine Society.
  • Li, H., Benoit, K., Swain, J., Ostrowski, N., & Motsko, S. (2013, October). Baseline Characteristics and Cardiovascular (CV) Comorbidities among United States Males Prior to Testosterone Treatment as Compared to Non-Users. In Pharmacoepidemiology and Drug Safety (Vol. 22, pp. 57-58).111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL.
  • Kelly, S. J., Ostrowski, N. L., & Wilson, M. A. (1999). Gender differences in brain and behavior: hormonal and neural bases. Pharmacology Biochemistry and Behavior, 64(4), 655-664.
  • Wu, X., Glinn, M. A., Ostrowski, N. L., Su, Y., Ni, B., Cole, H. W., & Paul, S. M. (1999). Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats. Brain research, 847(1), 98-104.
  • Vaccari, C., Lolait, S. J., & Ostrowski, N. L. (1998). Comparative Distribution of Vasopressin V1b and Oxytocin Receptor Messenger Ribonucleic Acids in Brain 1. Endocrinology, 139(12), 5015-5033.
  • Ostrowski, N. L. (1998). Oxytocin receptor mRNA expression in rat brain: implications for behavioral integration and reproductive success. Psychoneuroendocrinology, 23(8), 989-1004.
  • Kress, D. W., Ostrowski, N. L., McRae, B. L., & Arora, P. K. (1989). Mating suppresses splenic natural killer cell activity in male golden hamsters. Brain, behavior, and immunity, 3(3), 274-280.
  • Cruz, S. E., Ostrowski, N. L., & Noble, R. G. (1980). Mating and responsiveness to a nociceptive stimulus. Bulletin of the Psychonomic Society, 16(1), 55-56.
IU Signature